Skip to main content
NCBI home page
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1982 May 29;284(6329):1618–1621. doi: 10.1136/bmj.284.6329.1618

Meningococcal disease in Scandinavia.

H Peltola, K Jónsdóttir, A Lystad, C J Sievers, I Kallings
PMCID: PMC1498539  PMID: 6805630

Abstract

Scandinavia (Denmark, Finland, Iceland, Norway, and Sweden) comprises with mutual borders and 22.3 million inhabitants an area where the socioeconomic and cultural conditions are similar. Epidemic diseases, such as meningococcal infection, might therefore be expected to be uniformly distributed. An epidemiological study in the 10-year period 1970-9 shows, however, remarkable differences in the incidence, age, and serogroup and type distribution, as well as in the general dynamics of the disease. Three epidemics, two caused by different serotypes of group B (Norway and Iceland) and one by group A (Finland) occurred within the observation period. The annual overall incidence was generally around 3/100 000 but increased from fivefold (Finland) to eightfold (northern Norway) during epidemics. The epidemic strains caused infection in over 3000 patients and the loss of at least 250 lives. The overall case fatality rate was 8.6% (range 4.1-13.7%). Men were more susceptible and had a worse prognosis than women of the same age group. The group A epidemic in Finland was influenced by a large vaccination campaign, but this possibility was not feasible in the two other epidemics.

Full text

PDF
1618

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andersen B. M. Mortality in meningococcal infections. Scand J Infect Dis. 1978;10(4):277–282. doi: 10.3109/inf.1978.10.issue-4.04. [DOI] [PubMed] [Google Scholar]
  2. Artenstein M. S., Gold R., Zimmerly J. G., Wyle F. A., Schneider H., Harkins C. Prevention of meningococcal disease by group C polysaccharide vaccine. N Engl J Med. 1970 Feb 19;282(8):417–420. doi: 10.1056/NEJM197002192820803. [DOI] [PubMed] [Google Scholar]
  3. Berild D., Gedde-Dahl T. W., Abrahamsen T. Meningococcal disease in the Norwegian Armed Forces 1967-1979. Some epidemiological aspects. NIPH Ann. 1980 Dec;3(2):23–30. [PubMed] [Google Scholar]
  4. Bovre K., Holten E., Vik-Mo H., Brondbo A., Bratlid D., Bjark P., Moe P. J. Neisseria meningitidis infections in Northern Norway: an epidemic in 1974-1975 due mainly to group B organisms. J Infect Dis. 1977 Apr;135(4):669–672. doi: 10.1093/infdis/135.4.669. [DOI] [PubMed] [Google Scholar]
  5. Bøvre K., Gedde-Dahl T. W. Epidemiological patterns of meningococcal disease in Norway 1975-1979. NIPH Ann. 1980 Dec;3(2):9–22. [PubMed] [Google Scholar]
  6. Devine L. F., Pollard R. B., Krumpe P. E., Hoy E. S., Mammen R. E., Miller C. H., Peckinpaugh R. O. Field trial of the efficacy of a previously proposed regimen using minocycline and rifampin sequentially for the elimination of meningococci from healthy carriers. Am J Epidemiol. 1973 Jun;97(6):394–401. doi: 10.1093/oxfordjournals.aje.a121520. [DOI] [PubMed] [Google Scholar]
  7. Farquhar J. D., Hankins W. A., Desanctis A. N., Demeio J. L., Metzgar D. P. Clinical and serological evaluation of a meningococcal polysaccharide vaccine groups A, C, and Y. Proc Soc Exp Biol Med. 1978 Jan;157(1):79–82. doi: 10.3181/00379727-157-39995. [DOI] [PubMed] [Google Scholar]
  8. Farries J. S., Dickson W., Greenwood E., Malhotra T. R., Abbott J. D., Jones D. M. Meningococcal infections in Bolton, 1971-74. Lancet. 1975 Jul 19;2(7925):118–120. doi: 10.1016/s0140-6736(75)90016-1. [DOI] [PubMed] [Google Scholar]
  9. Feldman H. A. Meningococcal disease, 1965. JAMA. 1966 May 2;196(5):391–393. [PubMed] [Google Scholar]
  10. Frasch C. E., Chapman S. S. Classification of Neisseria meningitidis group B into distinct serotypes. I. Serological typing by a microbactericidal method. Infect Immun. 1972 Jan;5(1):98–102. doi: 10.1128/iai.5.1.98-102.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Frasch C. E., Robbins J. D. Protection against group B meningococcal disease. III. Immunogenicity of serotype 2 vaccines and specificity of protection in a guinea pig model. J Exp Med. 1978 Mar 1;147(3):629–644. doi: 10.1084/jem.147.3.629. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Frasch C. E. Role of protein serotype antigens in protection against disease due to Neisseria meningitidis. J Infect Dis. 1977 Aug;136 (Suppl):S84–S90. doi: 10.1093/infdis/136.supplement.s84. [DOI] [PubMed] [Google Scholar]
  13. Frøholm L. O. Review of meningococcal vaccines with emphasis on possible immunoprophylaxis of group B disease. NIPH Ann. 1980 Dec;3(2):67–74. [PubMed] [Google Scholar]
  14. Gold R., Winklehake J. L., Mars R. S., Artenstein M. S. Identification of an epidemic strain of group C Neisseria meningitidis by bactericidal serotyping. J Infect Dis. 1971 Dec;124(6):593–597. doi: 10.1093/infdis/124.6.593. [DOI] [PubMed] [Google Scholar]
  15. Greenwood B. M., Bradley A. K., Cleland P. G., Haggie M. H., Hassan-King M., Lewis L. S., Macfarlane J. T., Taqi A., Whittle H. C., Bradley-Moore A. M. An epidemic of meningococcal infection at Zaria, Northern Nigeria. 1. General epidemiological features. Trans R Soc Trop Med Hyg. 1979;73(5):557–562. doi: 10.1016/0035-9203(79)90052-x. [DOI] [PubMed] [Google Scholar]
  16. Holten E. Serotypes of Neisseria meningitidis isolated from patients in Norway during the first six months of 1978. J Clin Microbiol. 1979 Feb;9(2):186–188. doi: 10.1128/jcm.9.2.186-188.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Jacobson J. A., Chester T. J., Fraser D. W. An epidemic of disease due to serogroup B Neisseria meningitidis in Alabama: report of an investigation and community-wide prophylaxis with a sulfonamide. J Infect Dis. 1977 Jul;136(1):104–108. doi: 10.1093/infdis/136.1.104. [DOI] [PubMed] [Google Scholar]
  18. Jamba G., Bytchenko B., Causse G., Cvjetanović B., Ocirvan G., Tsend N., Kupul J., Tseren S., Batsuri A., Hisigdorj A. Immunization during a cerebrospinal meningitis epidemic in the Mongolian People's Republic, 1974-75. Bull World Health Organ. 1979;57(6):943–946. [PMC free article] [PubMed] [Google Scholar]
  19. Kostiukova N. N., Mironova T. K., Leshchinskaia E. V. Mikrobiologicheskaia kharakteristika meningokokkovoi infektsii v Moskve v gody periodicheskogo pod'ema zabolevaemosti (1968--1971) Zh Mikrobiol Epidemiol Immunobiol. 1974;00(5):29–32. [PubMed] [Google Scholar]
  20. Michalsen H., Haslund R., Steen-Johnsen J. Purulent meningitt hos barn. Et 6-årsmateriale. Tidsskr Nor Laegeforen. 1976 Dec 10;96(34-36):1776–1779. [PubMed] [Google Scholar]
  21. Mihalcu F., Paşolescu O., Coban V., Cuciureanu G., Dumitrescu S. Aspects actuels de la méningite cérébro-spinale épidémique en roumanie. Arch Roum Pathol Exp Microbiol. 1972 Mar;31(1):125–133. [PubMed] [Google Scholar]
  22. Moberg I. Sulfaresistenta meningokocker i sverige--förekomst, vaccination och kemoprofylax. Lakartidningen. 1975 Mar 5;72(10):971–973. [PubMed] [Google Scholar]
  23. Mäkelä P. H., Käyhty H., Weckström P., Sivonen A., Renkonen O. V. Effect of group-A meningococcal vaccine in army recruits in Finland. Lancet. 1975 Nov 8;2(7941):883–886. doi: 10.1016/s0140-6736(75)92125-x. [DOI] [PubMed] [Google Scholar]
  24. Mäkelä P. H., Peltola H. Group-specific meningococcal vaccination and epidemics caused by other groups of meningococci. Lancet. 1978 Oct 7;2(8093):780–781. doi: 10.1016/s0140-6736(78)92662-4. [DOI] [PubMed] [Google Scholar]
  25. Mäkelä P. H., Peltola H., Käyhty H., Jousimies H., Pettay O., Ruoslahti E., Sivonen A., Renkonen O. V. Polysaccharide vaccines of group A Neisseria meningtitidis and Haemophilus influenzae type b: a field trial in Finland. J Infect Dis. 1977 Aug;136 (Suppl):S43–S50. doi: 10.1093/infdis/136.supplement.s43. [DOI] [PubMed] [Google Scholar]
  26. Olcén P., Barr J., Kjellander J. Meningitis and bacteremia due to Neisseria meningitidis: clinical and laboratory findings in 69 cases from Orebro county, 1965 to 1977. Scand J Infect Dis. 1979;11(2):111–119. doi: 10.3109/inf.1979.11.issue-2.03. [DOI] [PubMed] [Google Scholar]
  27. Peltola H. Group A meningococcal polysaccharide vaccine and course of the group A meningococcal epidemic in Finland. Scand J Infect Dis. 1978;10(1):41–44. doi: 10.3109/inf.1978.10.issue-1.09. [DOI] [PubMed] [Google Scholar]
  28. Peltola H., Mäkelä H., Käyhty H., Jousimies H., Herva E., Hällström K., Sivonen A., Renkonen O. V., Pettay O., Karanko V. Clinical efficacy of meningococcus group A capsular polysaccharide vaccine in children three months to five years of age. N Engl J Med. 1977 Sep 29;297(13):686–691. doi: 10.1056/NEJM197709292971302. [DOI] [PubMed] [Google Scholar]
  29. Peltola H., Mäkelä P. H., ELO O., Pettay O., Renkonen O. V., Sivonen A. Vaccination against meningococcal group A disease in Finland 1974-75. Scand J Infect Dis. 1976;8(3):169–174. doi: 10.3109/inf.1976.8.issue-3.09. [DOI] [PubMed] [Google Scholar]
  30. Salmi I., Pettay O., Simula I., Kallio A. K., Waltimo O. An epidemic due to sulphonamide-resistant group A meningococci in the Helsinki area (Finland). Epidemiological and clinical observations. Scand J Infect Dis. 1976;8(4):249–254. doi: 10.3109/inf.1976.8.issue-4.06. [DOI] [PubMed] [Google Scholar]
  31. Sivonen A., Renkonen O. V., Weckström P., Koskenvuo K., Raunio V., Mäkelä P. H. The effect of chemoprophylactic use of rifampin and minocycline on rates of carriage of Neisseria meningitidis in army recruits in Finland. J Infect Dis. 1978 Mar;137(3):238–244. doi: 10.1093/infdis/137.3.238. [DOI] [PubMed] [Google Scholar]
  32. Wahdan M. H., Rizk F., el-Akkad A. M., el-Ghoroury A. A., Hablas R., Girgis N. I., Amer A., Boctar W., Sippel J. E., Gotschlich E. C. A controlled field trial of a serogroup A meningococcal polysaccharide vaccine. Bull World Health Organ. 1973 Jun;48(6):667–673. [PMC free article] [PubMed] [Google Scholar]
  33. Zollinger W. D., Mandrell R. E., Altieri P., Berman S., Lowenthal J., Artenstein M. S. Safety and immunogenicity of a Neisseria meningitidis type 2 protein vaccine in animals and humans. J Infect Dis. 1978 Jun;137(6):728–739. doi: 10.1093/infdis/137.6.728. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES